Sava Infond’s Hinge Health HNGE Stock Holding History

Sava Infond’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$632K	Buy	6,500 +4,800	+282%	+$421K	0.04%	136
2026 Q2	$141K	Buy	+1,700	New	+$92.3K	0.01%	209

Other funds holding HNGE

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Zweig-DiMenna Associates New York $1.3B AUM 120.13% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Sava Infond's HNGE Position: Q3 2026 in Review

Sava Infond increased its Hinge Health (HNGE) stake by 282% in Q3 2026, buying an estimated $421K and bringing the position to 6,500 shares worth $632K. The position accounts for 0.04% of the portfolio, ranked #136.

Sava Infond first reported a position in HNGE in Q2 2026 and has held it in 2 quarters since. 136 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.

Sava Infond held 6,500 shares of Hinge Health worth $632K as of Q3 2026.
Sava Infond bought 4,800 Hinge Health shares in Q3 2026, an estimated $421K.
Hinge Health made up 0.04% of Sava Infond's portfolio in Q3 2026, its #136 holding.
Sava Infond first reported a position in Hinge Health in Q2 2026 and has held it in 2 quarters since.
136 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.

Based on Sava Infond's 13F filing for Q3 2026, filed 28 Oct 2026.